Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart Disease and Stroke Statistics-2023 update: a Report from the American Heart Association. Circulation. 2023;147(8):e93–621.
Schwennesen HT, Andrade JG, Wood KA, Piccini JP. Ablation to reduce Atrial Fibrillation Burden and improve outcomes: JACC Review topic of the Week. J Am Coll Cardiol. 2023;82(10):1039–50.
Article PubMed PubMed Central Google Scholar
Chen H, Zhou X, Hu J, Li S, Wang Z, Zhu T, et al. Genetic insights into the association of statin and newer nonstatin drug target genes with human longevity: a mendelian randomization analysis. Lipids Health Dis. 2023;22(1):220.
Article CAS PubMed PubMed Central Google Scholar
Hayıroğlu M, Şaylık F, Çınar T, Tokgözoğlu L. Meta-analysis of the current research on the relationship between blood lipid levels and the occurrence of Atrial Fibrillation. Heart Lung Circ. 2023;32(10):1158–66.
Tajik B, Tuomainen TP, Jarroch R, Kauhanen J, Lip GYH, Isanejad M. Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: a report from the Kuopio Ischaemic Heart Disease risk factor study (KIHD). J Clin Lipidol. 2022;16(4):447–54.
Liu L, Liu X, Ding X, Chen H, Li W, Li H. Lipid levels and New-Onset Atrial Fibrillation in patients with Acute myocardial infarction. J Atheroscler Thromb. 2023;30(5):515–30.
Article CAS PubMed Google Scholar
Ding WY, Protty MB, Davies IG, Lip GYH. Relationship between lipoproteins, thrombosis, and atrial fibrillation. Cardiovasc Res. 2022;118(3):716–31.
Article CAS PubMed Google Scholar
Hanna IR, Heeke B, Bush H, Brosius L, King-Hageman D, Dudley SC Jr., et al. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm. 2006;3(8):881–6.
Article PubMed PubMed Central Google Scholar
Hingorani A, Humphries S. Nature’s randomised trials. Lancet. 2005;366(9501):1906–8.
Emdin CA, Khera AV, Kathiresan S, Mendelian Randomization. JAMA. 2017;318(19):1925–6.
Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of pleiotropy in mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195–208.
Article CAS PubMed PubMed Central Google Scholar
Graham SE, Clarke SL, Wu KH, Kanoni S, Zajac GJM, Ramdas S, et al. The power of genetic diversity in genome-wide association studies of lipids. Nature. 2021;600(7890):675–9.
Article CAS PubMed PubMed Central Google Scholar
Neale Lab GWAS of UK Biobank phenotypes. http://www.nealelab.is/uk-biobank/ (2018). Accessed 20 Feb 2023.
Pan-ancestry genetic analysis of the UK Biobank. https://pan.ukbb.broadinstitute.org (2018). Accessed 20 Feb 2023.
Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.
GTExConsortium. Genetic effects on gene expression across human tissues. Nature. 2017;550(7675):204–13.
Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508–18.
Article CAS PubMed PubMed Central Google Scholar
Nielsen JB, Thorolfsdottir RB, Fritsche LG, Zhou W, Skov MW, Graham SE, et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat Genet. 2018;50(9):1234–9.
Article CAS PubMed PubMed Central Google Scholar
Kanai M, Akiyama M, Takahashi A, Matoba N, Momozawa Y, Ikeda M, et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat Genet. 2018;50(3):390–400.
Article CAS PubMed Google Scholar
Christophersen IE, Rienstra M, Roselli C, Yin X, Geelhoed B, Barnard J, et al. Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet. 2017;49(6):946–52.
Article CAS PubMed PubMed Central Google Scholar
Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, et al. A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015;47(10):1121–30.
Article CAS PubMed PubMed Central Google Scholar
Yang C, Fagan AM, Perrin RJ, Rhinn H, Harari O, Cruchaga C. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes. Genome Med. 2022;14(1):140.
Article CAS PubMed PubMed Central Google Scholar
Burgess S, Thompson SG. Avoiding bias from weak instruments in mendelian randomization studies. Int J Epidemiol. 2011;40(3):755–64.
Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Martin RM, Lewis SJ, et al. Physical activity and risks of breast and colorectal cancer: a mendelian randomisation analysis. Nat Commun. 2020;11(1):597.
Article CAS PubMed PubMed Central Google Scholar
Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497–501.
Greco MF, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34(21):2926–40.
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–14.
Article PubMed PubMed Central Google Scholar
Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–98.
Article PubMed PubMed Central Google Scholar
Lin L, Lin J, Qiu J, Liufu N, Lin S, Wei F, et al. Genetic liability to multi-site chronic pain increases the risk of cardiovascular disease. Br J Anaesth. 2023;131(2):373–84.
Article CAS PubMed Google Scholar
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.
Article PubMed PubMed Central Google Scholar
Schmidt AF, Finan C, Gordillo-Marañón M, Asselbergs FW, Freitag DF, Patel RS, et al. Genetic drug target validation using mendelian randomisation. Nat Commun. 2020;11(1):3255.
Article CAS PubMed PubMed Central Google Scholar
Yin Q, Zhu L. Does co-localization analysis reinforce the results of mendelian. Randomization? Brain. 2024;147(1):e7–8.
Xue H, Shen X, Pan W. Constrained maximum likelihood-based mendelian randomization robust to both correlated and uncorrelated pleiotropic effects. Am J Hum Genet. 2021;108(7):1251–69.
留言 (0)